Evidence map›Paper›PMID 31059554›Full record

ArticlePloS one2019

Robustness of RNA sequencing on older formalin-fixed paraffin-embedded tissue from high-grade ovarian serous adenocarcinomas.

Yongmei Zhao, Monika Mehta, Ashley Walton, Keyur Talsania, Yelena Levin, Jyoti Shetty, Elizabeth M Gillanders, Bao Tran, Danielle Mercatante Carrick

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Comparison of RNA-Sequencing Methods for Degraded RNA.International journal of molecular sciences · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yongmei ZhaoNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research, Frederick, MD, United States of America.ORCID 0000-0003-0800-4658
Monika MehtaNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research, Frederick, MD, United States of America.
Ashley WaltonNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research, Frederick, MD, United States of America.
Keyur TalsaniaNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research, Frederick, MD, United States of America.
Yelena LevinNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research, Frederick, MD, United States of America.
Jyoti ShettyNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research, Frederick, MD, United States of America.
Elizabeth M GillandersDivision of Cancer Control and Population Sciences (DCCPS), National Cancer Institute, Rockville, MD, United States of America.
Bao TranNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research, Frederick, MD, United States of America.
Danielle Mercatante CarrickDivision of Cancer Control and Population Sciences (DCCPS), National Cancer Institute, Rockville, MD, United States of America.ORCID 0000-0002-9621-098X
Frederick National Laboratory for Cancer Research · USNational Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Formalin-fixed paraffin-embedded (FFPE) tissues are among the most widely available clinical specimens. Their potential utility as a source of RNA for transcriptome studies would greatly enhance population-based cancer studies. Although preliminary studies suggest FFPE tissue may be used for RNA sequencing, the effect of storage time on these specimens needs to be determined. We conducted this study to determine whether RNA in archived FFPE high-grade ovarian serous adenocarcinomas from Surveillance, Epidemiology and End Results (SEER) registries was present in sufficient quantity and quality for RNA-Seq analysis. FFPE tissues, stored from 7 to 32 years, were obtained from three SEER sites. RNA was extracted, quantified, quality assessed, and subjected to RNA-Seq (a whole transcriptome sequencing technology). FFPE specimens stored for longer periods of time had poorer RNA sample quality as indicated by negative correlations between specimen storage time and fragment distribution values (DV). In addition, sample contamination was a common issue among the RNA, with 41 of 67 samples having 5% to 48% bacterial contamination. However, regardless of specimen storage time and bacterial contamination, 60% of the samples yielded data that enabled gene expression quantification, identifying more than 10,000 genes, with the correlations among most biological replicates above 0.7. This study demonstrates that FFPE high-grade ovarian serous adenocarcinomas specimens stored in repositories for up to 32 years and under varying storage conditions are a promising source of RNA for RNA-Seq. We also describe certain caveats to be considered when designing RNA-Seq studies using archived FFPE tissues.

Indexed as

Cystadenocarcinoma, SerousFemaleFormaldehydeGene Expression ProfilingGene LibraryHumansOvarian NeoplasmsParaffin EmbeddingRNA, NeoplasmRNA-SeqSEER ProgramTime FactorsTissue FixationFormaldehydeRNA, Neoplasm

Identifiers

PMID31059554
PMCPMC6502345
OpenAlexW2943910283

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.